Seroprevalence of IgM and IgG anti-SARS-COV-2 and associated factors among agricultural workers in Colombia
- PMID: 36090798
- PMCID: PMC9441476
- DOI: 10.1016/j.nmni.2022.101026
Seroprevalence of IgM and IgG anti-SARS-COV-2 and associated factors among agricultural workers in Colombia
Abstract
Background: The population of South America has been severely affected by the COVID-19 pandemic. In this region, during the year 2020, high seroprevalence percentages were reported, which have been associated with the socioeconomic characteristics of the population, mainly in urban areas. However, a relative lack of information on the dynamics of the pandemic in rural areas of these countries, where the population is more vulnerable, is still present. This study determined antibody prevalence against SARS-CoV-2 in urban and rural food producing workers in Colombia.
Methods: A total of 1242 workers, urban and rural, linked to poultry, dairy, and meat production and supply chains, were analyzed through a sociodemographic survey and two serological tests against S and N proteins of SARS-CoV-2.
Results: 78.7% were male. 50.9% of the participants were rural inhabitants, with an average age of 40.9 years old. 39.2% had IgM and IgG against SARS-CoV-2 S protein and 31.3% against N protein for the same virus; 83.6% had not been tested with an RT-PCR test for COVID-19 and 75.7% did not report symptoms related to the disease. The associated risk factors were low education, OR: 1.46, greater number of cohabitants, OR: 1.36, and contact with people infected with COVID-19, OR: 2.03.
Conclusions: The seroprevalences found suggest an important interconnectivity between rural and urban areas, where asymptomatic subjects and sociodemographic factors facilitate the virus' spread in the population.
Keywords: Agricultural workers; COVID-19; Colombia; SARS-CoV-2 antibody levels.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119. Epidemiol Prev. 2020. PMID: 33412811 Italian.
-
High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.mSphere. 2021 Dec 22;6(6):e0068521. doi: 10.1128/mSphere.00685-21. Epub 2021 Nov 24. mSphere. 2021. PMID: 34817236 Free PMC article.
-
The seroprevalence of SARS-CoV-2 in a rural southwest community.J Osteopath Med. 2021 Feb 1;121(2):199-210. doi: 10.1515/jom-2020-0287. J Osteopath Med. 2021. PMID: 33567087
-
Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study.JMIRx Med. 2023 Oct 17;4:e29587. doi: 10.2196/29587. JMIRx Med. 2023. PMID: 37855218 Free PMC article.
-
Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra.Lancet Reg Health Eur. 2021 May 21;5:100119. doi: 10.1016/j.lanepe.2021.100119. eCollection 2021 Jun. Lancet Reg Health Eur. 2021. PMID: 34557824 Free PMC article.
Cited by
-
COVID-19 IgG seropositivity and its determinants in occupational groups of varying infection risks in two Andean cities of Ecuador before mass vaccination.PLoS One. 2024 Aug 29;19(8):e0309466. doi: 10.1371/journal.pone.0309466. eCollection 2024. PLoS One. 2024. PMID: 39208200 Free PMC article.
-
Serological surveillance reveals a high exposure to SARS-CoV-2 and altered immune response among COVID-19 unvaccinated Cameroonian individuals.PLOS Glob Public Health. 2024 Feb 12;4(2):e0002380. doi: 10.1371/journal.pgph.0002380. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38346064 Free PMC article.
References
-
- World Health Organization. WHO COVID-19 dashboard 2020.
-
- Figar S., Pagotto V., Luna L., Salto J., Manslau M.W., Mistchenko A.S., et al. Community-level SARS-CoV-2 seroprevalence survey in urban slum dwellers of Buenos Aires City, Argentina: a participatory research. MedRxiv. 2020 doi: 10.1101/2020.07.14.20153858. 2020.07.14.20153858. - DOI
-
- Instituto Nacional de Salud. Estudio Seroprevalencia de SARS-CoV-2 durante la epidemia en Colombia: estudio país 2020:1–14.
LinkOut - more resources
Full Text Sources
Miscellaneous